Position in ARGX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$575,217
+$118,081 QoQ
Shares Held
620
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#295
of 504 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREENLEAF TRUST holds $5,442,452 across 8 Biotechnology names. ARGX ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,995 | $2,481,165 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,353 | $843,649 | |
| 3 | ARGX |
Argenx SE
This page
|
620 | $575,217 | |
| 4 | INCY |
Incyte Corp
|
3,358 | $380,662 | |
| 5 | MRNA |
Moderna, Inc.
|
4,964 | $347,628 | |
| 6 | ATHE |
Alterity Therapeutics Ltd
|
62,000 | $332,940 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,560 | $248,109 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,157 | $233,082 |
All Filings in ARGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $575,217 | 620 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $457,136 | 626 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $520,548 | 619 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $444,011 | 602 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $328,527 | 596 | Shares | Defined | 2025-07-17 | |
| 2025-03-31 | $369,323 | 624 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $370,845 | 603 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $325,248 | 600 | Shares | Defined | 2024-10-22 | |
| 2021-09-30 | $262,740 | 870 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $217,974 | 724 | Shares | Defined | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||